2023-09-012024-08-312024-08-31false13928722ZEPHYR 100 LTD2025-05-16falseiso4217:GBPxbrli:pure139287222023-09-01139287222024-08-31139287222023-09-012024-08-31139287222022-09-01139287222023-08-31139287222022-09-012023-08-3113928722bus:SmallEntities2023-09-012024-08-3113928722bus:AuditExempt-NoAccountantsReport2023-09-012024-08-3113928722bus:FullAccounts2023-09-012024-08-3113928722bus:PrivateLimitedCompanyLtd2023-09-012024-08-3113928722core:WithinOneYear2024-08-3113928722core:AfterOneYear2024-08-3113928722core:WithinOneYear2023-08-3113928722core:AfterOneYear2023-08-3113928722core:ShareCapital2024-08-3113928722core:SharePremium2024-08-3113928722core:RevaluationReserve2024-08-3113928722core:OtherReservesSubtotal2024-08-3113928722core:RetainedEarningsAccumulatedLosses2024-08-3113928722core:ShareCapital2023-08-3113928722core:SharePremium2023-08-3113928722core:RevaluationReserve2023-08-3113928722core:OtherReservesSubtotal2023-08-3113928722core:RetainedEarningsAccumulatedLosses2023-08-3113928722core:LandBuildings2024-08-3113928722core:PlantMachinery2024-08-3113928722core:Vehicles2024-08-3113928722core:FurnitureFittings2024-08-3113928722core:OfficeEquipment2024-08-3113928722core:NetGoodwill2024-08-3113928722core:IntangibleAssetsOtherThanGoodwill2024-08-3113928722core:ListedExchangeTraded2024-08-3113928722core:UnlistedNon-exchangeTraded2024-08-3113928722core:LandBuildings2023-08-3113928722core:PlantMachinery2023-08-3113928722core:Vehicles2023-08-3113928722core:FurnitureFittings2023-08-3113928722core:OfficeEquipment2023-08-3113928722core:NetGoodwill2023-08-3113928722core:IntangibleAssetsOtherThanGoodwill2023-08-3113928722core:ListedExchangeTraded2023-08-3113928722core:UnlistedNon-exchangeTraded2023-08-3113928722core:LandBuildings2023-09-012024-08-3113928722core:PlantMachinery2023-09-012024-08-3113928722core:Vehicles2023-09-012024-08-3113928722core:FurnitureFittings2023-09-012024-08-3113928722core:OfficeEquipment2023-09-012024-08-3113928722core:NetGoodwill2023-09-012024-08-3113928722core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3113928722core:ListedExchangeTraded2023-09-012024-08-3113928722core:UnlistedNon-exchangeTraded2023-09-012024-08-3113928722core:MoreThanFiveYears2023-09-012024-08-3113928722core:Non-currentFinancialInstruments2024-08-3113928722core:Non-currentFinancialInstruments2023-08-3113928722dpl:CostSales2023-09-012024-08-3113928722dpl:DistributionCosts2023-09-012024-08-3113928722core:LandBuildings2023-09-012024-08-3113928722core:PlantMachinery2023-09-012024-08-3113928722core:Vehicles2023-09-012024-08-3113928722core:FurnitureFittings2023-09-012024-08-3113928722core:OfficeEquipment2023-09-012024-08-3113928722dpl:AdministrativeExpenses2023-09-012024-08-3113928722core:NetGoodwill2023-09-012024-08-3113928722core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3113928722dpl:GroupUndertakings2023-09-012024-08-3113928722dpl:ParticipatingInterests2023-09-012024-08-3113928722dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3113928722core:ListedExchangeTraded2023-09-012024-08-3113928722dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3113928722core:UnlistedNon-exchangeTraded2023-09-012024-08-3113928722dpl:CostSales2022-09-012023-08-3113928722dpl:DistributionCosts2022-09-012023-08-3113928722core:LandBuildings2022-09-012023-08-3113928722core:PlantMachinery2022-09-012023-08-3113928722core:Vehicles2022-09-012023-08-3113928722core:FurnitureFittings2022-09-012023-08-3113928722core:OfficeEquipment2022-09-012023-08-3113928722dpl:AdministrativeExpenses2022-09-012023-08-3113928722core:NetGoodwill2022-09-012023-08-3113928722core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3113928722dpl:GroupUndertakings2022-09-012023-08-3113928722dpl:ParticipatingInterests2022-09-012023-08-3113928722dpl:GroupUndertakingscore:ListedExchangeTraded2022-09-012023-08-3113928722core:ListedExchangeTraded2022-09-012023-08-3113928722dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-09-012023-08-3113928722core:UnlistedNon-exchangeTraded2022-09-012023-08-3113928722core:NetGoodwill2024-08-3113928722core:IntangibleAssetsOtherThanGoodwill2024-08-3113928722core:LandBuildings2024-08-3113928722core:PlantMachinery2024-08-3113928722core:Vehicles2024-08-3113928722core:FurnitureFittings2024-08-3113928722core:OfficeEquipment2024-08-3113928722core:AfterOneYear2024-08-3113928722core:WithinOneYear2024-08-3113928722core:ListedExchangeTraded2024-08-3113928722core:UnlistedNon-exchangeTraded2024-08-3113928722core:ShareCapital2024-08-3113928722core:SharePremium2024-08-3113928722core:RevaluationReserve2024-08-3113928722core:OtherReservesSubtotal2024-08-3113928722core:RetainedEarningsAccumulatedLosses2024-08-3113928722core:NetGoodwill2023-08-3113928722core:IntangibleAssetsOtherThanGoodwill2023-08-3113928722core:LandBuildings2023-08-3113928722core:PlantMachinery2023-08-3113928722core:Vehicles2023-08-3113928722core:FurnitureFittings2023-08-3113928722core:OfficeEquipment2023-08-3113928722core:AfterOneYear2023-08-3113928722core:WithinOneYear2023-08-3113928722core:ListedExchangeTraded2023-08-3113928722core:UnlistedNon-exchangeTraded2023-08-3113928722core:ShareCapital2023-08-3113928722core:SharePremium2023-08-3113928722core:RevaluationReserve2023-08-3113928722core:OtherReservesSubtotal2023-08-3113928722core:RetainedEarningsAccumulatedLosses2023-08-3113928722core:NetGoodwill2022-09-0113928722core:IntangibleAssetsOtherThanGoodwill2022-09-0113928722core:LandBuildings2022-09-0113928722core:PlantMachinery2022-09-0113928722core:Vehicles2022-09-0113928722core:FurnitureFittings2022-09-0113928722core:OfficeEquipment2022-09-0113928722core:AfterOneYear2022-09-0113928722core:WithinOneYear2022-09-0113928722core:ListedExchangeTraded2022-09-0113928722core:UnlistedNon-exchangeTraded2022-09-0113928722core:ShareCapital2022-09-0113928722core:SharePremium2022-09-0113928722core:RevaluationReserve2022-09-0113928722core:OtherReservesSubtotal2022-09-0113928722core:RetainedEarningsAccumulatedLosses2022-09-0113928722core:AfterOneYear2023-09-012024-08-3113928722core:WithinOneYear2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:CostValuation2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3113928722core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3113928722core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3113928722core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3113928722core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3113928722core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3113928722core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3113928722core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3113928722core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3113928722core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3113928722core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3113928722core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3113928722core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3113928722core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3113928722core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3113928722core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3113928722core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3113928722core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3113928722core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3113928722bus:Director12023-09-012024-08-31

ZEPHYR 100 LTD

Registered Number
13928722
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2024

ZEPHYR 100 LTD
Company Information
for the year from 1 September 2023 to 31 August 2024

Director

NARZIBEKOV, Rustambek

Registered Address

18 Thayer Street
London
W1U 3JY

Registered Number

13928722 (England and Wales)
ZEPHYR 100 LTD
Balance Sheet as at
31 August 2024

Notes

2024

2023

£

£

£

£

Current assets
Stocks343,48325,000
Debtors41,139,867429,378
Cash at bank and on hand22,778234,478
1,206,128688,856
Creditors amounts falling due within one year5(943,335)(450,573)
Net current assets (liabilities)262,793238,283
Total assets less current liabilities262,793238,283
Net assets262,793238,283
Capital and reserves
Called up share capital1-
Profit and loss account262,792238,283
Shareholders' funds262,793238,283
The financial statements were approved and authorised for issue by the Director on 16 May 2025, and are signed on its behalf by:
NARZIBEKOV, Rustambek
Director
Registered Company No. 13928722
ZEPHYR 100 LTD
Notes to the Financial Statements
for the year ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates. When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably. Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Stocks and work in progress
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential. At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20242023
Average number of employees during the year4428
3.Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential. At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

2024

2023

££
Raw materials and consumables43,48325,000
Total43,48325,000
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables38,7728,858
Amounts owed by group undertakings1,018,236372,018
Other debtors6,115-
Prepayments and accrued income76,74448,502
Total1,139,867429,378
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables647,478259,782
Amounts owed to related parties26,36614,275
Taxation and social security266,893164,325
Other creditors9472,192
Accrued liabilities and deferred income1,6519,999
Total943,335450,573
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Related party transactions
At the year end the company was owed £966,679 (2023 - £213,060) by CRG London Limited, a fellow group undertaking, in respect of an interest free loan which is repayable on demand. At the year end the company was owed £39,346 (2023 - £157,199) by Juzo London Limited, a fellow group undertaking, in respect of an interest free loan which is repayable on demand. At the year end the company was owed £12,821 (2023 - £1,759) by Pachamamarestaurant Limited, a fellow group undertaking, in respect of an interest free loan which is repayable on demand. At the year end the company owed £26,366 (2023 - £14,275) to Chicama Limited, a fellow group undertaking, in respect of an interest free loan which is repayable on demand.